s6y
Company name or ticker
Search
Contineum Therapeutics, Inc.
4
Stengone Carmine N.: Statement of changes in beneficial ownership of securities
Filed
Wednesday, July 8, 2026
Period
Jul 8, 2026
Accession number
0001628280-26-047710
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header